UK cancer mutation testing firm Biofidelity raises $12m

Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect mutations quicker than current approaches

Novo-backed $61m fundraising helps F2G prep for antifungal l...

Anglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening fungal infections through late-stage development and onto

UK biotech OMass raises £27.5m for GPCR drug discovery

China’s Adagene raises $69m for cancer immunotherapies

France's Doctolib is new digital health unicorn

Doctolib, the largest digital health service in Europe, has raised 150 million euros in a funding round, valuing it at over a billion euros.

Grey Wolf raises £10m for tumour 'illumination' tech

Immuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase tumour visibility.